These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17393857)

  • 1. [Merck's oral rotavirus vaccine RotaTeq suspected to cause invagination in infants].
    Zetterström R
    Lakartidningen; 2007 Feb 28-Mar 6; 104(9):646. PubMed ID: 17393857
    [No Abstract]   [Full Text] [Related]  

  • 2. RotaTeq: a new oral rotavirus vaccine.
    Med Lett Drugs Ther; 2006 Jul; 48(1240):61-3. PubMed ID: 16874281
    [No Abstract]   [Full Text] [Related]  

  • 3. Postmarketing monitoring of intussusception after RotaTeq vaccination--United States, February 1, 2006-February 15, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(10):218-22. PubMed ID: 17363890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jan; 119(1):171-82. PubMed ID: 17200286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus: disease and vaccine update, 2007.
    Stebbins S
    J Fam Pract; 2007 Feb; 56(2 Suppl Vaccines):S6-11. PubMed ID: 17270111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of on-time RotaTeq vaccination and long-term active surveillance.
    Anderson EJ
    Pediatrics; 2008 Nov; 122(5):1153-4; author reply 1154. PubMed ID: 18977997
    [No Abstract]   [Full Text] [Related]  

  • 7. Is there a safe age for vaccinating infants with tetravalent rhesus-human reassortant rotavirus vaccine?
    Gargiullo PM; Murphy TV; Davis RL
    J Infect Dis; 2006 Dec; 194(12):1793-4; author reply 1794-5. PubMed ID: 17109356
    [No Abstract]   [Full Text] [Related]  

  • 8. Rotavirus vaccination and intussusception: can we decrease temporally associated background cases of intussusception by restricting the vaccination schedule?
    Tai JH; Curns AT; Parashar UD; Bresee JS; Glass RI
    Pediatrics; 2006 Aug; 118(2):e258-64. PubMed ID: 16882770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotavirus vaccines.
    Ruiz LP
    N Engl J Med; 2006 Apr; 354(16):1747-51; author reply 1747-51. PubMed ID: 16625743
    [No Abstract]   [Full Text] [Related]  

  • 10. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007.
    Haber P; Patel M; Izurieta HS; Baggs J; Gargiullo P; Weintraub E; Cortese M; Braun MM; Belongia EA; Miller E; Ball R; Iskander J; Parashar UD
    Pediatrics; 2008 Jun; 121(6):1206-12. PubMed ID: 18519491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intussusception and an oral rotavirus vaccine.
    Nakagomi T
    N Engl J Med; 2001 Jun; 344(24):1866; author reply 1866-7. PubMed ID: 11407353
    [No Abstract]   [Full Text] [Related]  

  • 12. Intussusception and an oral rotavirus vaccine.
    DeWolfe Miller F
    N Engl J Med; 2001 Jun; 344(24):1866; author reply 1866-7. PubMed ID: 11407352
    [No Abstract]   [Full Text] [Related]  

  • 13. Intussusception and rotavirus vaccination: a review of the available evidence.
    Patel MM; Haber P; Baggs J; Zuber P; Bines JE; Parashar UD
    Expert Rev Vaccines; 2009 Nov; 8(11):1555-64. PubMed ID: 19863248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine.
    Belongia EA; Irving SA; Shui IM; Kulldorff M; Lewis E; Yin R; Lieu TA; Weintraub E; Yih WK; Li R; Baggs J;
    Pediatr Infect Dis J; 2010 Jan; 29(1):1-5. PubMed ID: 19907356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RotaTeq vaccine adverse events and policy considerations.
    Geier DA; King PG; Sykes LK; Geier MR
    Med Sci Monit; 2008 Mar; 14(3):PH9-16. PubMed ID: 18301365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More on RotaShield and intussusception: the role of age at the time of vaccination.
    Simonsen L; Viboud C; Elixhauser A; Taylor RJ; Kapikian AZ
    J Infect Dis; 2005 Sep; 192 Suppl 1():S36-43. PubMed ID: 16088803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pentavalent rotavirus vaccine, RotaTeq.
    Matson DO
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):195-9. PubMed ID: 17055370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The promise of new rotavirus vaccines.
    Glass RI; Parashar UD
    N Engl J Med; 2006 Jan; 354(1):75-7. PubMed ID: 16394305
    [No Abstract]   [Full Text] [Related]  

  • 19. Characteristics of an ideal rotavirus vaccine.
    Reisinger KS; Block SL
    Clin Pediatr (Phila); 2008 Jul; 47(6):555-63. PubMed ID: 18467670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotavirus vaccines.
    Simonsen L; Taylor RJ; Kapikian AZ
    N Engl J Med; 2006 Apr; 354(16):1747-51; author reply 1747-51. PubMed ID: 16625742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.